Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Financial Results of the Company for the Quarter and Nine Months ended 31 December 2023.21-01-2024
21-01-2024
Tatva Chintan Pharma Chem Results Earnings Call for Q3FY24
Conference Call with Tatva Chintan Pharma Chem Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.20-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the Quarter and Nine Months Ended 31 December 2023.20-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended On 31 December 2023
Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine Months ended on 31 December 202320-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 20.01.2024
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations'), we enclose herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31 December 2023. The said Results were reviewed and recommended by Audit Committee and approved by the Board of Directors of the Company in their respective meetings held on 20 January 2024. Further, we enclose herewith Limited Review Report issued by M/s. NDJ & Co., Chartered Accountants, (Firm Registration No. 136345W), Statutory Auditors of the Company as required under Regulation 33 of SEBI Listing Regulations. The above information shall be made available on the website of the Company at www.tatvachintan.com. The Board meeting commenced at 12:15 P.M. and concluded at 03:15 P.M.20-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and nine months ended 31 December 2023, is scheduled on Saturday, 20 January 2024 at 04:00 p.m. (IST). The Call is hosted by ICICI Securities and an invite in this regard is attached for your information and records. The above information is also being made available on the website of the Company at https://www.tatvachintan.com/.17-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, 20.01.2024
Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2024 ,inter alia, to consider and approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine month ended 31 December 2023. Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ''''designated persons'''' regarding the closure of the Trading Window for trading in the Company''s equity shares from 01 January 2024 till the expiry of 48 hours from the date the said financial results are made public. The above information is also being made available on the website of the Company at www.tatvachintan.com.11-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201806-01-2024
Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window
Intimation of Closure of Trading Window26-12-2023